Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Oct 6, 2006

Affymetrix and NimbleGen Systems Enter into Licensing Agreement

  • NimbleGen Systems obtained a nonexclusive, worldwide license to a number of Affymetrix patents covering the manufacture, use, and sales of nucleic acid microarrays and related products and services in the research field.

    “This licensing agreement with NimbleGen follows from a commercial relationship and enables both companies to better serve customers within the growing microarray market,” says Alan Sherr, vp and chief counsel for licensing at Affymetrix.



Be sure to take the GEN Poll

CRISPR Patent Controversy

Do you think recently released email from a former Broad Institute scientist to Jennifer Doudna will expedite a final legal decision on who owns the CRISPR patent?

More »